From February 5, 2024 to March 31, 2024, the company has repurchased 994,500 shares, representing 1.24% for CNY 19.99 million. With this, the company has completed the repurchase of 994,500 shares, representing 1.24% for CNY 19.99 million under the buyback announced on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 CNY | -1.51% | -1.98% | -31.38% |
1st Jan change | Capi. | |
---|---|---|
-31.38% | 200M | |
+39.92% | 734B | |
+32.83% | 591B | |
-6.42% | 350B | |
+15.88% | 315B | |
+1.68% | 276B | |
+15.09% | 238B | |
+9.53% | 206B | |
-5.19% | 204B | |
+5.64% | 161B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.